CHECK YOUR EMAIL!!!
VISIT https://cubix.com.cy/genehumdi/ to register now!!
The biggest Gene Editing for the treatment of Human Disease with be held in Limassol 8-10 April:Conference, WG sessions and Networking opportunities await in Cyprus
THE EXPECTATIONS
Last year the COST Action Meeting had a blast of Kick-off meeting, with close to a hundred assistant from over 20 nationalities. High level scientific, industry and regulatory presentations. Ex cursus, we enjoyed great scientific exchange and collaboration opportunities during the conference and the networking initiatives facilitated by our networking partners. Despite the intense agenda most GeneHumdi members end up thirsty for more.(You can refresh the meeting here abstracts: GeneHumdi2023Meetin Drive link)
We waited almost a year, and finally, the first draft of the most waited European Gene Editing the treatment of Human disease Meeting is here!!
The GeneHumdy Action thanks the extraordinary labour of the restless Cyprus organizing Committee together with our Action Chairs and to allow us to have a peak at the draft, that unfinished as is, it already loops amazingly appealing.
THE AGENDA 2024
The event extends over 3 days: 8, 9 and 10 of APRIL.
On the first day of the meeting, GeneHumdi is hosting a public conference driven by the action mission to reach all society groups and provide young and early career access to our network.
The Opening day features an outstanding Keynote talk to highlight gender roles in science and the educational session with prestigious prestigious speakers of science, healthcare, industry partners and selected abstracts from Inclusiveness Target Countries and Early Career Scientist. It will be followed by a technical session on new developments.
The second day will be a communion to strengthen the different working groups. Having members from each working group present and discuss the challenges and opportunity that the WG members have already identified.
The closing day will be an executive meeting for the rapporteurs and WG Leaders to discuss the state of the action and the task planned. They will set the blueprint for the consecution of the GeneHumdi Action deliverables in 2024.
THE OPENING CONFERENCE
| KEYNOTE OPENING | |
| Keynote on women in science | Marianna Prokopi-Demetriou RSL-Labs TheraMir | ProMedBioscience |
| EDUCATIONAL | |
| Chairs: Karim Benabdellah, Petros Patsali | |
| Current gene editing tools and trends – an overview | Carsten Wlederer he Cyprus Institute of Neurology & Genetics, Cyprus |
| Mitigation of on target mutagenesis with HDR-CRISPR | Claudio Mussolino University Hospital Freiburg, Germany |
| Off-target effects | Eivind Valen Oslo University, Norway |
| Viral and non-viral delivery methods | Stephen Hart University College London, UK |
| SELECTED ABSTRACTS | |
| OPEN SLOTS!! | Chairs: Alessia Cavazza, Laura Torella |
| ITC and ESC WELCOMED! |
| REGULATORY AND COMMERCIALISATION | |
| OPEN SLOTS!! | Chairs: Toni Cathomen, Carsten W Lederer |
| Gene editing services and reagents for clinical translation | Pending Confirmation |
| EMA/CAT: Regulating the editors | Pending Confirmation |
| Commercial products for clinical translation | Marianna Romito Maxcyte |
| Commercial products for clinical translation | Eleni Pananikolaou Miltenyi Biotec, Germany |
| Clinical Trials | Fulvio Mavilio Orchard Therapeutics |
| Clinical Trials | Julien Valton Cellectis, France |
| NEW DEVELOPMENTS | |
| Chairs: Rasmus Bak, Carlos J Ciudad | |
| Creation and discovery of new editors | Roman Jerala National Institute of Chemistry, Slovenia |
| Title TBD | Tal Shamia Synthego |
| In vivo delivery of editing tools using synthetic vectors | Luca Biasco University College London, UK |
| Persistent epigenome editing and mechanisms | Frank Buchholz Technical University Dresden, Germany |
| Editing in cancer therapy | Christos Georgiadis University College London, UK |
THE WORKING GROUP SESSIONS
Separate Sessions for each WG will be held in which selected active members and Tasl-leaders will present progres, challenges, and opportunities identified during the completion of the planned task. We are getting ready to welcome all GeneHumdi Members that can join our COST Action annual meeting. We are preparing a thrilling 3 day agenda including outstanding conferences of leaders, key partners and active members from all working groups
THE VENUE
The local organizing team leaded by Carsten Lederer, has secured The venue is Pefkos Hotel Limassol in Limassol,Cyprus (https://pefkoshotel.com) . The recently renovated Pefkos City Hotel – opened 7 June 2018. It is the nearest Hotel and within walking distance 10 to 15 minutes) to the Limassol Marina, the famous Medieval Castle area in the Old City and the nightlife at Saripolou Square as well as the main shopping area of Limassol City
Closest international Airports by road:
Paphos International Airport (40 min drive)
Larnaca International Airport (LCA) (49 min drive)
FUNDING OPORTUNITIIES
Our COST Action has grown to over 250 members, which makes impossible to grant sufficient funding for all members. However, WG leaders are entrusted with the task of identifying most active members inside each WG to make sure that they can continue their contribution in the annual meetings.
On Day1, there is a full session devoted to Inclusiveness Target countries and Early Career Scientist (Yes, graduated students and postdocs/industry under training are welcome!!). To fill this session, Abstract submission will be needed together with your application, and “Invited speakers” will be selected according to scientific criteria and GeneHumdi COST Action policies.
APPLICATION
Application for ITC and ECR will open son, please follow the CSOT Action 21113 (GeneHumdi) media and review the email address you provide upon signing up.
UPDATE!!!
PARTNERING OPPORTUNITIES
Given the dimension of the network, and the increasing interest in the meeting we appreciate Silver, Gold and Platinum Partners’ support to help provide networking opportunities to members and non-COST eligible assistants. Platinum partners are invited to introduce themselves during Day 1 Public conference. For more information on how to support the GeneHumdi mission during the meeting contact Carsten Lederer (lederer@cing.ac.cy)
(Local) Media opportunities
This event will bring together science, industry, healthcare, and regulatory key players from all around Europe. If you wish to help covering this influential meeting, or you are a press member interested in interviewing or report the event into your network, of for any other consults please refer to the SCC: javier.molina@genyo.es
See you at Limassol!!
Javier Molina & Carsten Lederer on behalf of the 2nd GeneHumdi Organizing Committee.
Granada, 3 February 2024
